661 related articles for article (PubMed ID: 22169272)
1. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
2. Serum bile acids in primary biliary cirrhosis.
Bloomer JR; Allen RM; Klatskin G
Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
[TBL] [Abstract][Full Text] [Related]
3. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
Rudolph G; Endele R; Senn M; Stiehl A
Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
[TBL] [Abstract][Full Text] [Related]
4. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
Azer SA; Coverdale SA; Byth K; Farrell GC; Stacey NH
J Gastroenterol Hepatol; 1996 Mar; 11(3):208-15. PubMed ID: 8742915
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of cholestatic liver disease].
Pleşa A
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
[TBL] [Abstract][Full Text] [Related]
6. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats.
Azer SA; Murray M; Farrell GC; Stacey NH
Hepatology; 1993 Nov; 18(5):1224-31. PubMed ID: 8225229
[TBL] [Abstract][Full Text] [Related]
7. Serum bile acid concentration after a test meal.
Fausa O
Scand J Gastroenterol; 1976; 11(3):229-32. PubMed ID: 1273500
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
Wunsch E; Trottier J; Milkiewicz M; Raszeja-Wyszomirska J; Hirschfield GM; Barbier O; Milkiewicz P
Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
[TBL] [Abstract][Full Text] [Related]
10. Plasma antioxidant levels in chronic cholestatic liver diseases.
Floreani A; Baragiotta A; Martines D; Naccarato R; D'odorico A
Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
Davies YK; Cox KM; Abdullah BA; Safta A; Terry AB; Cox KL
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.
Sauter G; Berr F; Beuers U; Fischer S; Paumgartner G
Hepatology; 1996 Jul; 24(1):123-6. PubMed ID: 8707250
[TBL] [Abstract][Full Text] [Related]
14. [Activity of neutral endopeptidase in serum of patients with primary biliary cirrhosis].
Horvát-Karajz K; Csepregi A; Nemesánszky E; Tulassay Z; Selmeci L; Szalay F
Orv Hetil; 2000 Apr; 141(18):963-5. PubMed ID: 10832380
[TBL] [Abstract][Full Text] [Related]
15. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
Buckley SE; DiPalma JA
Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
[TBL] [Abstract][Full Text] [Related]
16. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Batta AK; Salen G; Abroon J
Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G
Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
19. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
20. [No complaints, but constantly elevated cholestatic serum liver tests].
Kherbèche H
Praxis (Bern 1994); 2011 Jul; 100(14):865-7. PubMed ID: 21732301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
